3493-12-7 Usage
Uses
Different sources of media describe the Uses of 3493-12-7 differently. You can refer to the following data:
1. DL-Methionine Methylsulfonium Chloride is a compound comprised of γ-glutamyl peptide and amino acid that have a sucrose-like taste.
2. Vitamin U (DL-methionine methylsulfonium
chloride) is a natural methionine-derivative,
found as an active component in the
methionine cycle of plants where it serves as
a substrate for methyl transferases
(Augspurger et al., 2005). Historically this
compound has been utilized as either a cure or preventative against gastric and duodenal
ulcers (Nakamura et al., 1981).
Biochem/physiol Actions
S-Methionine methylsulfonium (SMMS) chloride is a derivative of methionine metabolism in some plants. SMMS has potent therapeutic effects on gastrointestinal ulceration potentially via its ability to promote dermal fibroblast migration and growth.
Check Digit Verification of cas no
The CAS Registry Mumber 3493-12-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,4,9 and 3 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 3493-12:
(6*3)+(5*4)+(4*9)+(3*3)+(2*1)+(1*2)=87
87 % 10 = 7
So 3493-12-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2S.ClH/c1-10(2)4-3-5(7)6(8)9;/h5H,3-4,7H2,1-2H3;1H
3493-12-7Relevant articles and documents
Double-headed sulfur-linked amino acids as first inhibitors for betaine-homocysteine S -methyltransferase 2
Mládková, Jana,Vaněk, Václav,Budě?ínsky, Milo?,Elbert, Tomá?,Demianová, Zuzana,Garrow, Timothy A.,Jirá?ek, Ji?í
experimental part, p. 6822 - 6831 (2012/10/07)
Betaine-homocysteine S-methyltransferase 2 (BHMT-2) catalyzes the transfer of a methyl group from S-methylmethionine to l-homocysteine, yielding two molecules of l-methionine. It is one of three homocysteine methyltransferases in mammals, but its overall contribution to homocysteine remethylation and sulfur amino acid homeostasis is not known. Moreover, recombinant BHMT-2 is highly unstable, which has slowed research on its structural and catalytic properties. In this study, we have prepared the first series of BHMT-2 inhibitors to be described, and we have tested them with human recombinant BHMT-2 that has been stabilized by copurification with human recombinant BHMT. Among the compounds synthesized, (2S,8RS,11RS)-5-thia-2,11-diamino-8-methyldodecanedioic acid (11) was the most potent (Kiapp ~77 nM) and selective inhibitor of BHMT-2. Compound 11 only weakly inhibited human BHMT (IC 50 about 77 μM). This compound (11) may be useful in future in vivo studies to probe the physiological significance of BHMT-2 in sulfur amino acid metabolism.